CLOV - Clover Health Investments Corp - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLOV is currently covered by 3 analysts with an average price target of $4.15. This is a potential upside of $1.26 (43.6%) from yesterday's end of day stock price of $2.89.

Clover Health Investments Corp's activity chart (see below) currently has 19 price targets and 17 ratings on display. The stock rating distribution of CLOV is 40% HOLD and 60% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.19% with an average time for these price targets to be met of 148.89 days.

Highest price target for CLOV is $4.5, Lowest price target is $4, average price target is $4.25.

Most recent stock forecast was given by RICHARD CLOSE from CANACCORD on 03-Mar-2025. First documented stock forecast 01-Feb-2021.

Best performing analysts who are covering CLOV - Clover Health Investments Corp:

Kevin Fischbeck Ralph Giacobbe Jailendra Singh Richard Close Gary Taylor Jason Cassorla Whit Mayo Jonathan Yong Jonathan Yon

Currently out of the existing stock ratings of CLOV, 2 are a HOLD (40%), 3 are a BUY (60%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Richard Close (CANACCORD)

Buy

$4.5

$1.46 (48.03%)

$3.2

4 months 29 days ago
(03-Mar-2025)

3/6 (50%)

$0.86 (23.63%)

277

Please subscribe to see the analyst performance score

Jonathan Yong (UBS)

Hold

$0.96 (31.58%)

9 months 25 days ago
(07-Oct-2024)

3/3 (100%)

$0.31 (8.40%)

Please subscribe to see the analyst performance score

Jason Cassorla (CITI)

Hold

$1.8

$-1.24 (-40.79%)

$3.5

2 years 8 months 16 days ago
(16-Nov-2022)

2/3 (66.67%)

$0.43 (31.39%)

683

Please subscribe to see the analyst performance score

Whit Mayo (LEERINK)

Hold

$1.5

$-2.96 (-66.37%)

2 years 8 months 24 days ago
(08-Nov-2022)

4/4 (100%)

$0.21 (16.28%)

Please subscribe to see the analyst performance score

Gary Taylor (COWEN)

$2.1 (233.33%)

3 years 6 months ago
(02-Feb-2022)

2/2 (100%)

$0.25 (9.09%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is CLOV (Clover Health Investments Corp) average time for price targets to be met?

On average it took 148.89 days on average for the stock forecasts to be realized with a an average price target met ratio 85.19

Which analyst has the current highest performing score on CLOV (Clover Health Investments Corp) with a proven track record?

KEVIN FISCHBECK

Which analyst has the current lower performing score on CLOV (Clover Health Investments Corp) with a proven track record?

JONATHAN YON

Which analyst has the most public recommendations on CLOV (Clover Health Investments Corp)?

Kevin Fischbeck works at BAML and has 17 price targets and 10 ratings on CLOV

Which analyst is the currently most bullish on CLOV (Clover Health Investments Corp)?

Kevin Fischbeck with highest potential upside - $8.22

Which analyst is the currently most reserved on CLOV (Clover Health Investments Corp)?

Whit Mayo with lowest potential downside - -$2.96

Clover Health Investments Corp in the News

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians

Clover Health Investments, Corp. Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in chronic disease care, and supporting independent doctors caring for seniors in rural and other underserved areas WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE)...

Craig-Hallum Reiterates a Buy Rating on Clover Health Investments (CLOV), Sets a $6 PT

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the 13 Stocks Under $5 With High Upside Potential. In a report released on May 7, Matt Hewitt from Craig-Hallum reiterated a Buy rating on Clover Health Investments, Corp. (NASDAQ:CLOV) with a price target of $6.00.Is Clover Health Investments, Corp. (CLOV) the Best Multibagger Penny Stock to...